.FDA turns down psychedelic MDMA-assisted treatment for post-traumatic stress disorder NBC NewsF.D.A. Downtrends to Approve MDMA Treatment, Seeking Additional Study The New York TimesFDA Turns Down Ecstasy-Based Medication The Stock market JournalFDA declines to approve novel MDMA treatment to treat post-traumatic stress disorder, along with request for even more trial records CNNFDA turns down initially experimental to handle post-traumatic stress disorder, requiring additional study The Washington Post.